FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

USA USA

Industries

  • Medicine ‎4
    • Pharmaceuticals ‎4

Contact Info

Location

Teva Neuroscience, Inc

  • 4Product
  • 1Types
  • 1Industry

About Company

Teva Pharmaceutical Products Ltd. is the parent company of Teva Pharmaceuticals in the United States. The foundation of our success—and at the heart of Teva—is our vision to be the most indispensable medicines company for the world, executing on our obligation to our patients, customers, shareholders and employees. Established in 1901, today Teva Pharmaceutical Products Ltd. ranks among the top 10 pharmaceutical companies in the world. Teva is active in 60

Teva Pharmaceutical Products Ltd. is the parent company of Teva Pharmaceuticals in the United States. The foundation of our success—and at the heart of Teva—is our vision to be the most indispensable medicines company for the world, executing on our obligation to our patients, customers, shareholders and employees. Established in 1901, today Teva Pharmaceutical Products Ltd. ranks among the top 10 pharmaceutical companies in the world. Teva is active in 60 countries, with over 46,000 dedicated employees worldwide. Teva is committed to providing consumers with access to high-quality healthcare by developing, producing and marketing affordable generic, innovative and specialty products, as well as active pharmaceutical ingredients. Following our vision, we pursue robust organic growth. This strategy is complemented by key alliances with exemplary partners. We extend our presence into new markets and add selectively to our capabilities. We balance investment in growth with return to our investors. We commit ourselves to challenging and meeting unmet medical, societal and patient needs.

Products

Copaxone®

MEDICINE - PHARMACEUTICALS   |  MULTIPLE SCLEROSIS

Copaxone®

Copaxone®

MEDICINE - PHARMACEUTICALS   |  MULTIPLE SCLEROSIS

Copaxone®

Copaxone®

MEDICINE - PHARMACEUTICALS   |  MULTIPLE SCLEROSIS

Copaxone®

Copaxone®

MEDICINE - PHARMACEUTICALS   |  MULTIPLE SCLEROSIS

Copaxone®

Analytical Reports